Counterpoint Mutual Funds LLC Makes New Investment in Owens & Minor, Inc. $OMI

Key Points

• Counterpoint Mutual Funds LLC made a new investment in Owens & Minor, Inc. by acquiring 98,955 shares valued at approximately $900,000, increasing their stake to about 0.13% of the company.
• Major shareholder Coliseum Capital Management purchased 720,000 shares at an average price of $5.15 per share, increasing their ownership by 6.23% and bringing their total shareholding to over 12 million shares.
• Owens & Minor reported $0.26 earnings per share for the last quarter, falling short of consensus estimates of $0.27, and the company has set FY 2025 guidance at 1.020-1.070 EPS.

Counterpoint Mutual Funds LLC bought a new position in Owens & Minor, Inc. (NYSE:OMI - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 98,955 shares of the company's stock, valued at approximately $900,000. Counterpoint Mutual Funds LLC owned about 0.13% of Owens & Minor as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Owens & Minor by 4.0% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 42,930 shares of the company's stock valued at $561,000 after purchasing an additional 1,662 shares during the last quarter. Versant Capital Management Inc raised its holdings in shares of Owens & Minor by 537.6% during the first quarter. Versant Capital Management Inc now owns 3,201 shares of the company's stock valued at $29,000 after purchasing an additional 2,699 shares during the last quarter. Parallel Advisors LLC raised its holdings in shares of Owens & Minor by 1,387.0% during the first quarter. Parallel Advisors LLC now owns 3,316 shares of the company's stock valued at $30,000 after purchasing an additional 3,093 shares during the last quarter. Quarry LP purchased a new position in shares of Owens & Minor during the first quarter valued at approximately $34,000. Finally, State of Wyoming raised its holdings in shares of Owens & Minor by 21.2% during the first quarter. State of Wyoming now owns 28,105 shares of the company's stock valued at $254,000 after purchasing an additional 4,907 shares during the last quarter. 98.04% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Owens & Minor news, major shareholder Coliseum Capital Management, L acquired 720,000 shares of the stock in a transaction on Tuesday, August 12th. The stock was acquired at an average price of $5.15 per share, for a total transaction of $3,708,000.00. Following the completion of the transaction, the insider directly owned 12,282,955 shares of the company's stock, valued at $63,257,218.25. This trade represents a 6.23% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have acquired a total of 1,537,852 shares of company stock worth $8,099,544 in the last three months. 3.69% of the stock is owned by company insiders.

Owens & Minor Price Performance

Shares of NYSE:OMI opened at $5.42 on Tuesday. The company has a debt-to-equity ratio of 3.32, a quick ratio of 0.83 and a current ratio of 0.86. The firm has a fifty day moving average price of $6.08 and a 200 day moving average price of $7.23. Owens & Minor, Inc. has a fifty-two week low of $4.56 and a fifty-two week high of $16.38. The firm has a market cap of $418.64 million, a price-to-earnings ratio of -0.35 and a beta of 1.03.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its earnings results on Monday, August 11th. The company reported $0.26 earnings per share for the quarter, missing analysts' consensus estimates of $0.27 by ($0.01). Owens & Minor had a positive return on equity of 26.59% and a negative net margin of 13.78%.The company had revenue of $681.90 million for the quarter, compared to the consensus estimate of $2.73 billion. During the same quarter in the prior year, the company posted $0.36 EPS. Owens & Minor's revenue was up 3.3% compared to the same quarter last year. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. As a group, sell-side analysts expect that Owens & Minor, Inc. will post 1.51 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Zacks Research cut shares of Owens & Minor from a "hold" rating to a "strong sell" rating in a report on Tuesday, September 2nd. Robert W. Baird reduced their target price on shares of Owens & Minor from $10.00 to $7.00 and set an "outperform" rating for the company in a report on Tuesday, August 12th. Citigroup reaffirmed a "buy" rating and set a $7.00 target price (down from $11.00) on shares of Owens & Minor in a report on Tuesday, August 12th. JPMorgan Chase & Co. reduced their target price on shares of Owens & Minor from $7.00 to $6.00 and set an "underweight" rating for the company in a report on Wednesday, August 27th. Finally, UBS Group set a $7.00 target price on shares of Owens & Minor in a report on Wednesday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, Owens & Minor presently has a consensus rating of "Hold" and a consensus price target of $7.63.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.